Results 181 to 190 of about 11,777 (278)

PDE4B promotes JNK/NLRP3 activation in the nucleus pulposus and mediates intervertebral disc degeneration. [PDF]

Sci Rep
Xu W, Dhar R, Li K, Zheng D, He M, Ding W, Xin L, Xu B, He Y, Peng Q, Tang H.   +10 more
europepmc   +1 more source

Targeting Aquaporin-5 by Phosphodiesterase 4 Inhibition Offers New Therapeutic Opportunities for Ovarian Ischemia Reperfusion Injury in Rats. [PDF]

Reprod Sci
Bozkurt A, Karakoy Z, Aydin P, Ozdemir B, Toktay E, Halici Z, Cadirci E.   +6 more
europepmc   +1 more source

Effects of rolipram and siguazodan on the human isolated bronchus and their interaction with isoprenaline and sodium nitroprusside [PDF]

, 1993
Yueming Qian, Emmanuel Naline, Jessica Karlsson, David Raeburn, Charles Advenier   +4 more
openalex   +1 more source

How close are we to a cAMP- and cGMP-theory-based pharmacological therapy for fragile X syndrome? [PDF]

Cell Rep Med
Bardoni B, Gwizdek C, Maurin T.
europepmc   +1 more source

Rolipram, a Phosphodiesterase Inhibitor, in the Treatment of Two Male Patients with Congenital Nephrogenic Diabetes insipidus [PDF]

, 1990
Daniel G. Bichet, Nicole Ruel, Marie‐Françoise Arthus, Michèle Lonergan   +3 more
openalex   +1 more source

The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction. [PDF]

Calcif Tissue Int
Hong JM, Gerard-O'Riley RL, Acton D, Alam I, Econs MJ, Bruzzaniti A.   +5 more
europepmc   +1 more source

Anti-inflammatory properties of the β₂-receptor agonist salbutamol and the PDE4 inhibitor rolipram are mediated by MKP-1

, 2018
Tiina Keränen, Tuija Hömmö, Tiina Leppänen, Mari Hämäläinen, Eeva Moilanen, Riku Korhonen   +5 more
openalex   +2 more sources

A Stereoselective Synthesis of (R)-(-)-rolipram from L-Glutamic Acid [PDF]

, 1997
Andrés Emanuel Díaz, Jorge G. Siro, José L. Garcı́a-Navı́o, Juan J. Vaquero, Julio Álvarez‐Buílla   +4 more
openalex   +1 more source

PDE4D: A Multipurpose Pharmacological Target. [PDF]

Int J Mol Sci
Lusardi M, Rapetti F, Spallarossa A, Brullo C.   +3 more
europepmc   +1 more source

Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory [PDF]

, 1998
Mark Barad, Roussoudan Bourtchouladze, Danny G. Winder, Hava Golan, Eric R. Kandel   +4 more
openalex   +1 more source